Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma

Shinji Itoh, Takashi Maeda, Mitsuo Shimada, Shin Ichi Aishima, Ken Shirabe, Shinji Tanaka, Yoshihiko Maehara

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

Purpose: Although hepatocellular carcinoma (HCC) is the most common cancer of the human liver, the mechanisms that regulate HCC development and progression remain unclear. The aim of this study was to investigate whether focal adhesion kinase (FAK) is involved in the progression of human HCC. Experimental Design: Western blot analysis for FAK was performed on three HCC cell lines. We reviewed 64 consecutive patients who had undergone initial liver resection for HCC without preoperative treatment. Immunohistochemistry analysis for FAK was performed on paraffin-embedded tissues. FAK expression was confirmed by Western blot analysis in several clinical samples. We investigated the correlation between FAK expression and clinical outcome. Results: FAK proteins were detected in all HCC cell lines. Hepatocytes in the normal liver and chronic hepatitis with or without cirrhosis were negative for immunohistochemical staining for FAK expression. Cytoplasmic FAK expression was observed in 18 of 64 patients (28.1%), and this positive staining was correlated with gender (P < 0.05), a lower level of serum albumin (P < 0.05), and portal venous invasion (P < 0.01). Positive staining for FAK was associated with significantly poorer survival (P < 0.05). In multivariate analysis, FAK overexpression was an independent factor in determining the prognosis of patients. Conclusions: These data suggest that FAK plays an important role in promoting tumor progression, especially vascular invasion, in HCC. FAK could play an important role in HCC progression and would be a novel target for HCC therapeutics as well as a prognostic marker.

Original languageEnglish
Pages (from-to)2812-2817
Number of pages6
JournalClinical Cancer Research
Volume10
Issue number8
DOIs
Publication statusPublished - Apr 15 2004

Fingerprint

Focal Adhesion Protein-Tyrosine Kinases
Hepatocellular Carcinoma
Western Blotting
Staining and Labeling
Cell Line
Negative Staining
Liver
Chronic Hepatitis
Liver Neoplasms
Serum Albumin
Paraffin
Blood Vessels
Hepatocytes
Fibrosis
Research Design
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Itoh, S., Maeda, T., Shimada, M., Aishima, S. I., Shirabe, K., Tanaka, S., & Maehara, Y. (2004). Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma. Clinical Cancer Research, 10(8), 2812-2817. https://doi.org/10.1158/1078-0432.CCR-1046-03

Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma. / Itoh, Shinji; Maeda, Takashi; Shimada, Mitsuo; Aishima, Shin Ichi; Shirabe, Ken; Tanaka, Shinji; Maehara, Yoshihiko.

In: Clinical Cancer Research, Vol. 10, No. 8, 15.04.2004, p. 2812-2817.

Research output: Contribution to journalArticle

Itoh, S, Maeda, T, Shimada, M, Aishima, SI, Shirabe, K, Tanaka, S & Maehara, Y 2004, 'Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma', Clinical Cancer Research, vol. 10, no. 8, pp. 2812-2817. https://doi.org/10.1158/1078-0432.CCR-1046-03
Itoh, Shinji ; Maeda, Takashi ; Shimada, Mitsuo ; Aishima, Shin Ichi ; Shirabe, Ken ; Tanaka, Shinji ; Maehara, Yoshihiko. / Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma. In: Clinical Cancer Research. 2004 ; Vol. 10, No. 8. pp. 2812-2817.
@article{a3cdfe0719e54a73aa8558fbb416d959,
title = "Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma",
abstract = "Purpose: Although hepatocellular carcinoma (HCC) is the most common cancer of the human liver, the mechanisms that regulate HCC development and progression remain unclear. The aim of this study was to investigate whether focal adhesion kinase (FAK) is involved in the progression of human HCC. Experimental Design: Western blot analysis for FAK was performed on three HCC cell lines. We reviewed 64 consecutive patients who had undergone initial liver resection for HCC without preoperative treatment. Immunohistochemistry analysis for FAK was performed on paraffin-embedded tissues. FAK expression was confirmed by Western blot analysis in several clinical samples. We investigated the correlation between FAK expression and clinical outcome. Results: FAK proteins were detected in all HCC cell lines. Hepatocytes in the normal liver and chronic hepatitis with or without cirrhosis were negative for immunohistochemical staining for FAK expression. Cytoplasmic FAK expression was observed in 18 of 64 patients (28.1{\%}), and this positive staining was correlated with gender (P < 0.05), a lower level of serum albumin (P < 0.05), and portal venous invasion (P < 0.01). Positive staining for FAK was associated with significantly poorer survival (P < 0.05). In multivariate analysis, FAK overexpression was an independent factor in determining the prognosis of patients. Conclusions: These data suggest that FAK plays an important role in promoting tumor progression, especially vascular invasion, in HCC. FAK could play an important role in HCC progression and would be a novel target for HCC therapeutics as well as a prognostic marker.",
author = "Shinji Itoh and Takashi Maeda and Mitsuo Shimada and Aishima, {Shin Ichi} and Ken Shirabe and Shinji Tanaka and Yoshihiko Maehara",
year = "2004",
month = "4",
day = "15",
doi = "10.1158/1078-0432.CCR-1046-03",
language = "English",
volume = "10",
pages = "2812--2817",
journal = "Clinical Cancer Research",
issn = "1078-0432",
publisher = "American Association for Cancer Research Inc.",
number = "8",

}

TY - JOUR

T1 - Role of Expression of Focal Adhesion Kinase in Progression of Hepatocellular Carcinoma

AU - Itoh, Shinji

AU - Maeda, Takashi

AU - Shimada, Mitsuo

AU - Aishima, Shin Ichi

AU - Shirabe, Ken

AU - Tanaka, Shinji

AU - Maehara, Yoshihiko

PY - 2004/4/15

Y1 - 2004/4/15

N2 - Purpose: Although hepatocellular carcinoma (HCC) is the most common cancer of the human liver, the mechanisms that regulate HCC development and progression remain unclear. The aim of this study was to investigate whether focal adhesion kinase (FAK) is involved in the progression of human HCC. Experimental Design: Western blot analysis for FAK was performed on three HCC cell lines. We reviewed 64 consecutive patients who had undergone initial liver resection for HCC without preoperative treatment. Immunohistochemistry analysis for FAK was performed on paraffin-embedded tissues. FAK expression was confirmed by Western blot analysis in several clinical samples. We investigated the correlation between FAK expression and clinical outcome. Results: FAK proteins were detected in all HCC cell lines. Hepatocytes in the normal liver and chronic hepatitis with or without cirrhosis were negative for immunohistochemical staining for FAK expression. Cytoplasmic FAK expression was observed in 18 of 64 patients (28.1%), and this positive staining was correlated with gender (P < 0.05), a lower level of serum albumin (P < 0.05), and portal venous invasion (P < 0.01). Positive staining for FAK was associated with significantly poorer survival (P < 0.05). In multivariate analysis, FAK overexpression was an independent factor in determining the prognosis of patients. Conclusions: These data suggest that FAK plays an important role in promoting tumor progression, especially vascular invasion, in HCC. FAK could play an important role in HCC progression and would be a novel target for HCC therapeutics as well as a prognostic marker.

AB - Purpose: Although hepatocellular carcinoma (HCC) is the most common cancer of the human liver, the mechanisms that regulate HCC development and progression remain unclear. The aim of this study was to investigate whether focal adhesion kinase (FAK) is involved in the progression of human HCC. Experimental Design: Western blot analysis for FAK was performed on three HCC cell lines. We reviewed 64 consecutive patients who had undergone initial liver resection for HCC without preoperative treatment. Immunohistochemistry analysis for FAK was performed on paraffin-embedded tissues. FAK expression was confirmed by Western blot analysis in several clinical samples. We investigated the correlation between FAK expression and clinical outcome. Results: FAK proteins were detected in all HCC cell lines. Hepatocytes in the normal liver and chronic hepatitis with or without cirrhosis were negative for immunohistochemical staining for FAK expression. Cytoplasmic FAK expression was observed in 18 of 64 patients (28.1%), and this positive staining was correlated with gender (P < 0.05), a lower level of serum albumin (P < 0.05), and portal venous invasion (P < 0.01). Positive staining for FAK was associated with significantly poorer survival (P < 0.05). In multivariate analysis, FAK overexpression was an independent factor in determining the prognosis of patients. Conclusions: These data suggest that FAK plays an important role in promoting tumor progression, especially vascular invasion, in HCC. FAK could play an important role in HCC progression and would be a novel target for HCC therapeutics as well as a prognostic marker.

UR - http://www.scopus.com/inward/record.url?scp=1942534181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942534181&partnerID=8YFLogxK

U2 - 10.1158/1078-0432.CCR-1046-03

DO - 10.1158/1078-0432.CCR-1046-03

M3 - Article

C2 - 15102689

AN - SCOPUS:1942534181

VL - 10

SP - 2812

EP - 2817

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 8

ER -